Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
13,848 | Dovepress* | 13,848 | 0+ | 3,309 | 13,848 |
Totals | 13,848 | 0 | 3,309 | 13,848 | |
*Since 12 April 2010 +Since July 2016 |
View citations on Google Scholar